Childhood macroprolactinomas amenable to dopamine agonist treatment By Eleanor McDermid, Senior medwireNews Reporter Dopamine agonist treatment normalises prolactin amounts in about three-quarters of children with macroprolactinomas, show findings from a large series. The 77 patients in the scholarly study were diagnosed in three French specialist centres before the age of twenty years. Related StoriesTwo genetic variants interact to alter the brain responses to high-calorie foodsDisrupting specific signaling pathway in the brain can cause overeating of high fat foodsUnwanted formation of arteries in the brain may cause intractable problems for Parkinson's disease patientsIndeed, pubertal disorders were the feature that resulted in the discovery of the adenoma in 49 percent of the patients overall click here .
‘To our knowledge, no previous study has examined working in adult life among individuals diagnosed as having bacterial meningitis in childhood,’ the authors create. Related StoriesAdvances entirely mount human brain imaging: an interview with Patrick Myles, President, Huron Digital PathologyStudy identifies proteins that may help in treating deafnessInner ear damage brain warnings from nerve cells Casper Roed, M.D., of Copenhagen University Hospital, Copenhagen, Denmark, and colleagues conducted a report to estimate educational accomplishment and economic self-sufficiency among kids surviving bacterial meningitis weighed against the general populace. The nationwide population-centered cohort study used nationwide registries of Danish-born kids diagnosed as having meningococcal, pneumococcal, or H influenzae meningitis in the time 1977-2007> The study included individuals who had a brief history of childhood meningococcal> Among H influenzae meningitis patients, 5.5 % fewer had completed senior high school and 6.5 % fewer had completed higher education by age 35 years compared with members of the populace comparison cohort.